Rachel Shaw signed Bridgebio Oncology Therapeutics' 2024 Form 5500 as plan administrator.
Signer names are public record from the Form 5500 e-signature.
Bridgebio Oncology Therapeutics' EIN is 81-3636735.
Download the official 2024 Form 5500 (PDF) for Bridgebio Oncology Therapeutics from the U.S. Department of Labor's EFAST2 system.
Download the official 2024 Form 5500 (PDF)Bridgebio Oncology Therapeutics' plan includes automatic enrollment, profit-sharing, a 401(k) feature, ERISA 404(c) participant direction, a default investment (QDIA).